The proposed Rare Cancers EPIC Working Group led by Lynnette Fernandez-Cuesta and Matthieu Foll has been approved by the EPIC Steering Committee.

We are looking forward to using this Rare Cancers EPIC Working Group as a way to better understand the etiology of neuroendocrine tumors and sarcomas.